Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Seoyoung Catherine Kim, Sc.D., M.D.

Co-Author

This page shows the publications co-authored by Seoyoung Kim and Rishi Desai.
Connection Strength

18.838
  1. Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study. Rheumatology (Oxford). 2021 Mar 22.
    View in: PubMed
    Score: 0.952
  2. Trends in Utilization of Urate-Lowering Therapies Following the US Food and Drug Administration's Boxed Warning on Febuxostat. Arthritis Rheumatol. 2021 03; 73(3):542-543.
    View in: PubMed
    Score: 0.942
  3. Comparative Risk of Diabetes Mellitus in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Drugs: A Cohort Study. ACR Open Rheumatol. 2020 Apr; 2(4):222-231.
    View in: PubMed
    Score: 0.891
  4. Utilization and Treatment Costs of Tumor Necrosis Factor Inhibitors After the Introduction of Biosimilar Infliximab in the United States. Arthritis Rheumatol. 2020 06; 72(6):1036-1038.
    View in: PubMed
    Score: 0.891
  5. Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement. JAMA Netw Open. 2019 07 03; 2(7):e198061.
    View in: PubMed
    Score: 0.845
  6. Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study. Arthritis Rheumatol. 2019 06; 71(6):892-900.
    View in: PubMed
    Score: 0.835
  7. Association of Geography and Access to Health Care Providers With Long-Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort Study. Arthritis Rheumatol. 2019 05; 71(5):712-721.
    View in: PubMed
    Score: 0.830
  8. An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout. PLoS One. 2018; 13(2):e0193622.
    View in: PubMed
    Score: 0.770
  9. Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-a inhibitors or nonbiologic agents: a cohort study. CMAJ. 2017 Nov 27; 189(47):E1438-E1447.
    View in: PubMed
    Score: 0.757
  10. Alendronate and Hip Fracture in Patients Using Glucocorticoids. JAMA. 2017 11 07; 318(17):1711-1712.
    View in: PubMed
    Score: 0.754
  11. Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States: A Cohort Study of Publicly and Privately Insured Patients. J Manag Care Spec Pharm. 2017 Aug; 23(8):809-814.
    View in: PubMed
    Score: 0.740
  12. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ. 2017 Mar 06; 356:j895.
    View in: PubMed
    Score: 0.719
  13. Tumor Necrosis Factor-a Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. Epidemiology. 2016 May; 27(3):414-22.
    View in: PubMed
    Score: 0.678
  14. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions. Arthritis Rheumatol. 2016 05; 68(5):1183-9.
    View in: PubMed
    Score: 0.678
  15. Identification of smoking using Medicare data--a validation study of claims-based algorithms. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):472-5.
    View in: PubMed
    Score: 0.664
  16. An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score. Arthritis Res Ther. 2015 Apr 13; 17:83.
    View in: PubMed
    Score: 0.631
  17. Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study. Arthritis Care Res (Hoboken). 2015 Apr; 67(4):457-66.
    View in: PubMed
    Score: 0.629
  18. The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing. Inflamm Bowel Dis. 2021 08 19; 27(9):1427-1434.
    View in: PubMed
    Score: 0.245
  19. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology (Oxford). 2021 08 02; 60(8):3689-3698.
    View in: PubMed
    Score: 0.244
  20. Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs. ACR Open Rheumatol. 2021 Aug; 3(8):531-539.
    View in: PubMed
    Score: 0.243
  21. Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020. J Gen Intern Med. 2021 Jun 07.
    View in: PubMed
    Score: 0.242
  22. Risk of Hospitalized Serious Infection After Initiating Ustekinumab or Other Biologics for Psoriasis or Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2021 May 10.
    View in: PubMed
    Score: 0.240
  23. Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol. J Am Heart Assoc. 2021 04 06; 10(7):e020045.
    View in: PubMed
    Score: 0.238
  24. Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement. Arthritis Care Res (Hoboken). 2021 Jan 15.
    View in: PubMed
    Score: 0.235
  25. Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2020 Dec 30.
    View in: PubMed
    Score: 0.234
  26. Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study. Alzheimers Dement (N Y). 2020; 6(1):e12095.
    View in: PubMed
    Score: 0.233
  27. Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study. Arthritis Care Res (Hoboken). 2020 10; 72(10):1383-1391.
    View in: PubMed
    Score: 0.230
  28. Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study. Semin Arthritis Rheum. 2020 06; 50(3):401-408.
    View in: PubMed
    Score: 0.217
  29. Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars. Pharmacoepidemiol Drug Saf. 2020 07; 29(7):757-769.
    View in: PubMed
    Score: 0.212
  30. Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study. BMJ Open. 2019 06 19; 9(6):e027495.
    View in: PubMed
    Score: 0.211
  31. Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis. JAMA Dermatol. 2019 06 01; 155(6):700-707.
    View in: PubMed
    Score: 0.210
  32. Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis. JAMA Intern Med. 2019 06 01; 179(6):741-749.
    View in: PubMed
    Score: 0.210
  33. Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study. Semin Arthritis Rheum. 2019 10; 49(2):222-228.
    View in: PubMed
    Score: 0.207
  34. Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study. Ann Rheum Dis. 2019 04; 78(4):456-464.
    View in: PubMed
    Score: 0.205
  35. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study. Circulation. 2018 09 11; 138(11):1116-1126.
    View in: PubMed
    Score: 0.200
  36. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. JAMA Netw Open. 2018 07 06; 1(3):e180826.
    View in: PubMed
    Score: 0.197
  37. Association of Medicare's Bundled Payment Reform With Changes in Use of Vitamin D Among Patients Receiving Maintenance Hemodialysis: An Interrupted Time-Series Analysis. Am J Kidney Dis. 2018 08; 72(2):178-187.
    View in: PubMed
    Score: 0.196
  38. Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease. J Rheumatol. 2018 08; 45(9):1240-1248.
    View in: PubMed
    Score: 0.195
  39. Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015. Arthritis Care Res (Hoboken). 2018 05; 70(5):791-796.
    View in: PubMed
    Score: 0.193
  40. Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout. J Am Coll Cardiol. 2018 03 06; 71(9):994-1004.
    View in: PubMed
    Score: 0.193
  41. Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study. J Am Heart Assoc. 2018 01 24; 7(3).
    View in: PubMed
    Score: 0.191
  42. Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis. Arthritis Res Ther. 2017 07 05; 19(1):159.
    View in: PubMed
    Score: 0.184
  43. Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy. Pharmacoepidemiol Drug Saf. 2021 Sep 08.
    View in: PubMed
    Score: 0.061
  44. Calibrating Real-World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn's Disease. Clin Pharmacol Ther. 2021 May 24.
    View in: PubMed
    Score: 0.060
  45. Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol. 2021 03; 224(3):290.e1-290.e22.
    View in: PubMed
    Score: 0.057
  46. Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross-National Comparison Between the US and Taiwan. Arthritis Care Res (Hoboken). 2018 01; 70(1):30-38.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.